©2015 by Longbow Capital LLP  

Longbow Capital LLP is authorised and regulated by the Financial Conduct Authority. FCA No. 402753

Contact Us


01603 757509

Barnham Broom,

Honingham Road,

Norwich NR9 4DD




Tax Benefits


Income Tax Relief

CGT Relief

IHT Relief


Loss Relief



Longbow Capital


LONGBOW CAPITAL is a leading investor in UK-based, unquoted companies, predominantly in the health and well being sector. The Partners have combined experience of investing in over 50 unquoted companies.


Longbow identifies investment opportunities in emerging UK-based companies that offer scope to generate exceptional returns for investors.


There is significant tax relief offered to UK private investors investing in Qualifying Companies based in the UK. Tax relief is available through the Enterprise Investment Scheme (EIS) against income tax and capital gains tax, as well as through Business Property Relief (BPR) against inheritance tax. Investments may also be eligible to be held within SIPP portfolios.


Our investments may not be suitable for all investors. Unquoted investments are high risk and usually illiquid until a Company is sold or floated on a recognised exchange.


Longbow client investors need to be High New Worth Individuals and private investors who can be classified as Elective Professional Clients, in accordance with FCA rules.

Latest News 

Sky Medical and Calon Cardio feature in UK Lifescience Industry Magazine

Read the article here

Abzena successfully secures over 25 chemistry and ADC service agreements

Read the article here

Destiny Pharma - China Medical System Holdings Limited invests £3m

Read the article here


Destiny Pharma - Development and commercial agreement finalised

Read the article here

Abzena - Half year results: Growth strategy progressing

Read the article here

Abzena secures ADC manufacturing services contract

Read the article here

UK's first heart pump targets 2018 clinical trial - BBC News

24th June 2017

Read the news article here

Calon - What's it like to live with a mechanical heart pump? - BBC News

9th December 2017

Read the article here

Abzena selects Sartorius single-use bioreactors for US sites

5th January 2018

Read the article here